Moderna Inc (MRNA)
38.25
+1.31
(+3.55%)
USD |
NASDAQ |
Nov 21, 16:00
38.21
-0.04
(-0.10%)
After-Hours: 20:00
Moderna Total Liabilities (Quarterly): 3.876B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.876B |
| June 30, 2024 | 3.968B |
| March 31, 2024 | 3.912B |
| December 31, 2023 | 4.572B |
| September 30, 2023 | 5.995B |
| June 30, 2023 | 4.935B |
| March 31, 2023 | 5.262B |
| December 31, 2022 | 6.735B |
| September 30, 2022 | 8.064B |
| June 30, 2022 | 8.058B |
| March 31, 2022 | 10.53B |
| December 31, 2021 | 10.52B |
| September 30, 2021 | 10.80B |
| Date | Value |
|---|---|
| June 30, 2021 | 9.449B |
| March 31, 2021 | 8.856B |
| December 31, 2020 | 4.776B |
| September 30, 2020 | 1.891B |
| June 30, 2020 | 539.12M |
| March 31, 2020 | 426.67M |
| December 31, 2019 | 414.61M |
| September 30, 2019 | 339.09M |
| June 30, 2019 | 346.72M |
| March 31, 2019 | 360.17M |
| December 31, 2018 | 431.91M |
| September 30, 2018 | 412.73M |
| December 31, 2017 | 459.19M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
414.61M
Minimum
Dec 2019
10.80B
Maximum
Sep 2021
5.679B
Average
5.098B
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Merck & Co Inc | 72.97B |
| Pfizer Inc | 126.92B |
| Novavax Inc | 2.239B |
| Vertex Pharmaceuticals Inc | 6.609B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.80B |
| Shareholders Equity (Quarterly) | 11.93B |
| Current Ratio | 4.392 |